Cerebrospinal fluid abnormalities in a phase III trial of Avonex® (IFNβ-1a) for relapsing multiple sclerosis1Studies supported by the National Multiple Sclerosis Society (grants RG2019, RG2827); the NINDS (NS26321); and Biogen Inc.1
- 1 January 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 93 (1-2), 8-14
- https://doi.org/10.1016/s0165-5728(98)00174-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Interferon β‐1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase‐9Annals of Neurology, 1996
- Interferon beta‐1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosisAnnals of Neurology, 1996
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- CSF oligoclonal bands, MRI, and the diagnosis of multiple sclerosisActa Neurologica Scandinavica, 1995
- Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Cerebrospinal fluidAnnals of Neurology, 1994
- Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide.The Journal of Experimental Medicine, 1993
- Intrathecal IgG Synthesis and IgG Index after Intensive and Chronic Immunosuppressive Treatment of Multiple SclerosisAnnals of the New York Academy of Sciences, 1984
- The use and abuse of the cerebrospinal fluid IgG profile in the adult: A practical evaluationAnnals of Neurology, 1980
- Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosisScandinavian Journal of Clinical and Laboratory Investigation, 1977